Clinical Trial

Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
To assess 1-year recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) who are at high risk of Inguinal orchiectomy recurrence usingTACE combined with icaritin
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-14.
Status change: Not Yet Recruiting → Recruiting 2025-09-21
Trial Details
NCT Number NCT06644937
Lead Sponsor Zhujiang Hospital
Conditions Hepatocellular Carcinoma (HCC)
Enrollment 30 participants
Start Date 2024-11-29
Primary Completion 2026-10-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-23